
  <rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
      <title>Boss BioTech USA Blog</title>
      <link>https://blog.bossbiotechusa.com/blog</link>
      <description>High-purity laboratory research reagents: chemical specifications, triple receptor agonist profiles, and laboratory handling guides.</description>
      <language>en-us</language>
      <managingEditor>support@bossbiotechusa.com (Boss BioTech USA)</managingEditor>
      <webMaster>support@bossbiotechusa.com (Boss BioTech USA)</webMaster>
      <lastBuildDate>Wed, 08 Jul 2026 00:00:00 GMT</lastBuildDate>
      <atom:link href="https://blog.bossbiotechusa.com/tags/tirzepatide/feed.xml" rel="self" type="application/rss+xml"/>
      
  <item>
    <guid>https://blog.bossbiotechusa.com/blog/retatrutide-vs-tirzepatide-vs-semaglutide</guid>
    <title>How Do Retatrutide, Tirzepatide, and Semaglutide Compare? A Chemical &amp; Receptor-Selectivity Reference</title>
    <link>https://blog.bossbiotechusa.com/blog/retatrutide-vs-tirzepatide-vs-semaglutide</link>
    <description>A chemistry-only comparison of Retatrutide, Tirzepatide, and Semaglutide by receptor selectivity (triple vs dual vs mono), CAS, molecular weight, and verified in vitro potency.</description>
    <pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate>
    <author>support@bossbiotechusa.com (Boss BioTech USA)</author>
    <category>retatrutide</category><category>tirzepatide</category><category>semaglutide</category><category>comparison</category><category>receptor-selectivity</category>
  </item>

    </channel>
  </rss>
